The pandemic has influenced every company in every market. But companies that focus on synthetic DNA have been in a unique position to help. That’s why Codex DNA has played, and continues to play, a crucial role in the fight against Covid-19. The creation and release of the world’s first full-length synthetic genomes for the three Covid virus variants is a game-changer, not just for Covid but for the healthcare industry and the approach scientists will bring to future health crises. We sat down with Jason Lehmann, product marketing manager for Codex DNA to dive into how the genomes were created, how Codex DNA responded to the pandemic and what the future of synthetic DNA will look like. Join us as we dive into this fascinating world and better understand the scientific community’s approach to Covid.
Learn more about Codex DNA: https://codexdna.com
Watch their webinar with Dr. Jesse Erasmus: https://us06web.zoom.us/webinar/register/1016173187660/WN_LpNvnyarRimjIK7YTgYB8A
Information
- Show
- PublishedMay 6, 2021 at 3:12 AM UTC
- Length25 min
- Season2
- Episode18
- RatingClean